학술논문
PECATI: A Multicentric, Open-Label, Single-Arm Phase II Study to Evaluate the Efficacy and Safety of Pembrolizumab and Lenvatinib in Pretreated B3-Thymoma and Thymic Carcinoma Patients
Document Type
Short Communication
Author
Source
In Clinical Lung Cancer May 2022 23(3):e243-e246
Subject
Language
ISSN
1525-7304